- Home
- MDXH vs ZTEK Comparison
MDXH vs ZTEK Comparison
Compare MDXH & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- ZTEK
- Stock Information
- Founded
- MDXH 2003
- ZTEK 2008
- Country
- MDXH Belgium
- ZTEK Canada
- Employees
- MDXH N/A
- ZTEK N/A
- Industry
- MDXH
- ZTEK Major Chemicals
- Sector
- MDXH
- ZTEK Industrials
- Exchange
- MDXH Nasdaq
- ZTEK Nasdaq
- Market Cap
- MDXH 100.5M
- ZTEK 82.2M
- IPO Year
- MDXH 2021
- ZTEK N/A
- Fundamental
- Price
- MDXH $1.77
- ZTEK $0.94
- Analyst Decision
- MDXH Strong Buy
- ZTEK
- Analyst Count
- MDXH 2
- ZTEK 0
- Target Price
- MDXH $7.00
- ZTEK N/A
- AVG Volume (30 Days)
- MDXH 98.8K
- ZTEK 35.2K
- Earning Date
- MDXH 11-06-2024
- ZTEK 11-14-2024
- Dividend Yield
- MDXH N/A
- ZTEK N/A
- EPS Growth
- MDXH N/A
- ZTEK N/A
- EPS
- MDXH N/A
- ZTEK N/A
- Revenue
- MDXH $84,708,000.00
- ZTEK $29,132.00
- Revenue This Year
- MDXH $26.39
- ZTEK N/A
- Revenue Next Year
- MDXH $18.68
- ZTEK N/A
- P/E Ratio
- MDXH N/A
- ZTEK N/A
- Revenue Growth
- MDXH 33.01
- ZTEK 42.65
- 52 Week Low
- MDXH $0.35
- ZTEK $0.50
- 52 Week High
- MDXH $4.64
- ZTEK $1.59
- Technical
- Relative Strength Index (RSI)
- MDXH 26.20
- ZTEK 64.40
- Support Level
- MDXH $1.62
- ZTEK $0.76
- Resistance Level
- MDXH $2.24
- ZTEK $0.85
- Average True Range (ATR)
- MDXH 0.13
- ZTEK 0.09
- MACD
- MDXH -0.01
- ZTEK 0.02
- Stochastic Oscillator
- MDXH 28.57
- ZTEK 88.24
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.